Categories: Entertainment

BrowserStack Becomes the First Platform to Enable Playwright Testing on Real iOS Devices with Safari

DUBLIN, June 12, 2025 /PRNewswire/ — BrowserStack, the world’s leading software testing platform, today announced support for Playwright tests on real iOS devices with Safari—becoming the first platform to close one of the most persistent gaps in browser test automation.

- Advertisement -

Playwright has become one of the most popular test automation frameworks globally. However, until now, developers and QA engineers couldn’t use it to test websites on real iOS devices with Safari. They had to rely on Playwright’s desktop browser emulation, which often misses real iOS device-specific issues and edge cases—resulting in false positives and incomplete test coverage.

- Advertisement -

“With iOS driving 28% of global web traffic, testing Safari on real iOS devices was the biggest missing piece in Playwright,” said Nakul Aggarwal, CTO and Co-founder of BrowserStack. “Now, teams can confidently run Playwright tests on real iOS devices, ensuring consistent, reliable results across different browsers and devices.”

- Advertisement -

BrowserStack Automate now supports Playwright tests on real iPhones and iPads using Safari, enabling teams to:

- Advertisement -
  • Run parallel tests across 1000+ real iOS and Android device-browser combinations
  • Get accurate, reliable results with real-device testing
  • Capture network, video, and text logs in one place for faster debugging
  • Simulate real-world conditions—such as location, network speed, timezone, and orientation

“With BrowserStack, we have saved up to 80% of our quality automation costs. We can test on two times more devices and browsers and up to three times more website sampling from releases,” said Darius Dumitrescu, Global Technical Delivery Manager at L’Oréal.

- Advertisement -

Playwright testing on real iOS devices with Safari is now available on BrowserStack Automate. Try now for free.

- Advertisement -

About BrowserStack

- Advertisement -

BrowserStack is the world’s leading software testing platform powering over two million tests every day across 19 global data centers. BrowserStack helps Amazon, NVIDIA, MongoDB, Microsoft, X, and over 50,000 customers deliver quality software at speed by moving testing to their Cloud. BrowserStack’s platform provides instant access to 20,000+ real mobile devices on a highly reliable cloud infrastructure that effortlessly scales as testing needs grow. With BrowserStack, Dev and QA teams can move fast while delivering an amazing experience for every customer.

- Advertisement -

Founded in 2011, BrowserStack is a privately held company backed by Accel, Bond, and Insight Partners. For more information, visit https://www.browserstack.com.

- Advertisement -

Media Contact
Press Relations Team
press@browserstack.com

- Advertisement -

Logo: https://mma.prnewswire.com/media/2490455/5273672/BrowserStack_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/browserstack-becomes-the-first-platform-to-enable-playwright-testing-on-real-ios-devices-with-safari-302480159.html

- Advertisement -
PRNW Agency

Recent Posts

AARAV Fragrances & Flavors Strengthens Leadership Team with Appointment of Yatin Sheth as COO – Ingredient Business

MUMBAI, India, June 22, 2026 /PRNewswire/ -- AARAV Fragrances & Flavors Pvt. Ltd., one of…

7 minutes ago

Moldova Digital Summit 2026: EU Commissioner Marta Kos Praises Moldova as a Digital Success Story

CHISINAU, Moldova, June 22, 2026 /PRNewswire/ -- Moldova Digital Summit 2026 (MDS26) brought approximately 4,000…

1 hour ago

The Search For India’s Next Breakthrough Innovations Begins As Marico Innovation Foundation Invites Applications For Indian Innovation Icons 2027

The biennial platform continues its legacy of championing scalable solutions creating socio-economic and environmental changeThe…

1 hour ago

UN GLOBAL COMPACT LAUNCHES FIRST PRACTICAL GUIDE FOR COMPANIES LEADING ON BLENDED FINANCE

New Playbook empowers businesses to take an active role in structuring deals within the $24B…

1 hour ago

MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe…

11 hours ago

Boston Dental Named The Best Dentist in Boston

Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services June 19,…

11 hours ago